DEC 07, 2021 8:00 AM PST

T Cells in COVID-19 - Translating research findings into clinical options

Sponsored by: Miltenyi Biotec
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract
Date:  December 7, 2021
Time: 8:00am (PST),  11:00am (EST)
 
Analysis of SARS-CoV-2–specific T cells is important to understand their role during acute disease and in long-term protection after infection or vaccination. Though studying these rare cells comes with challenges, gained insights offer great opportunities in fighting COVID-19. This webinar will cover both sides.
 
There is growing evidence that SARS-CoV-2–specific T cells play an important role in the recovery from COVID-19. Researchers have reported the presence of a SARS-CoV-2–specific memory T cell population in the blood of convalescent donors. These cells could be used for treating COVID-19 patients in certain cases.
 
At Miltenyi Biotec, we offer a complete workflow for the study of virus-specific T cells. Also, several preparation methods for clinical-grade cell products using our CliniMACS® Technology have been described.1-3 In 2021, Antonio Perez et al. reported improvement of symptoms in nine patients in a phase 1 clinical trial using convalescent donor-derived CD45RA-depleted memory T cells. The study indicates the potential of adoptive cell therapy to treat COVID-19.4 More research is needed to further develop this new exciting field of cell therapy.
 
1 Cooper et al. (2021) Front. Immunol. 11: 598402. 2 Leung et al. (2020) Adv. Cell Gene Ther. 2020: e101. 3 Ferreras et al. (2021) Front. Cell Dev. Biol. 9: 620730. 4 Pérez-Martínez et al. (2021) EClinicalMedicine 39: 101086.
 
Learning Objectives
  • Review tools for SARS-CoV-2–specific T cell research
  • Discuss how to overcome key challenges, such as high sample numbers, low cell frequencies, inefficient stimulation, and operator safety
  • Review published preclinical and clinical data on cell therapy for COVID-19
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
Loading Comments...
Show Resources